{"id":956,"date":"2024-07-24T09:33:24","date_gmt":"2024-07-24T01:33:24","guid":{"rendered":"https:\/\/cytoarm.com\/?page_id=956"},"modified":"2024-09-10T21:37:51","modified_gmt":"2024-09-10T13:37:51","slug":"overview-of-cell-therapy","status":"publish","type":"page","link":"https:\/\/cytoarm.com\/zh\/overview-of-cell-therapy\/","title":{"rendered":"The Breakthrough of Armed-T Cell Therapy"},"content":{"rendered":"
\n
\n

CytoArm\u2019s Armed-T Platform
Solves Major Challenges of T cell therapy<\/h2>\n\n\n\n
\n
CytoArm addresses these critical challenges with its Armed-T platform<\/strong>. Instead of relying on viral vectors, our platform employs bi-functional antibodies (BsAb)<\/strong>, which use a much smaller amount of antibody compared to traditional antibody drugs. This lower concentration minimizes the impact on the human body, reducing the risk of severe side effects, and providing a safer, more controllable therapy.<\/div>\n<\/div>\n<\/div>\n <\/div><\/section>\n\n\n\n
\n
\n
\n

The Challenges of Current T Cell Therapies Armed-T Platform Solves<\/h2>\n\n\n\n

Modern T cell therapies have shown immense potential in treating various cancers, but they come with significant challenges.<\/h5>\n<\/div>\n\n\n\n
\n
\u25c6 Oncogenic Risk<\/strong>: The primary issues is the use of viral vectors for gene editing that may couse oncogenic potential, where the virus may unintentionally activate cancer-causing genes, leading to serious health concerns. By avoiding viral vectors, we eliminate the potential for viral-based oncogenesis, a significant safety concern in gene therapies<\/strong>.<\/mark>
\u25c6 Cost-Intensive QC<\/strong>: This viral approach often requires large financial investments in quality control (QC) due to the inherent risks associated with using viruses. Our non-viral approach significantly reduces the need<\/mark> <\/strong>for costly quality control processes typically required for viral-based therapies.
\u25c6 Difficult to Manage Side Effects<\/strong>: If side effects occur, current T cell therapy can be extremely difficult to manage or reverse. These high concentrations and genetic modifications can lead to unpredictable, long-term consequences for patients. With an extremely lower antibody concentration, the risk of long-lasting side effects is minimized, making our therapy far safer and easier to manage.<\/strong><\/mark><\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\n

Advantages of CytoArm\u2019s Armed-T Platform: <\/h2>\n\n\n\n

The Armed-T platform<\/strong> brings a revolutionary approach to T cell therapies, offering several key advantages:<\/h4>\n<\/div>\n\n\n\n
\n
CytoArm’s Armed-T platform addresses these challenges head-on, offering significant advantages over traditional T-cell therapies:
\u2714 High Purity:<\/strong> Our innovative Armed-T technology ensures that T-cell products are manufactured with a purity level exceeding 90%. This high purity enhances the safety and efficacy of the therapy, leading to more consistent and reliable patient outcomes.
\u2714 High Adaptability:<\/strong> The Armed-T platform is designed to be highly adaptable, allowing it to target a broad range of cancers and autoimmune diseases. By equipping T cells with bi-functional antibodies (BsAbs), our technology can be tailored to address over 50 different diseases, providing treatment options for patients with various types of cancers.
\u2714 Virus-Free Production: <\/strong>Unlike traditional T-cell therapies that rely on viral vectors, Armed-T uses a non-viral approach, reducing the risk of off-target effects and improving the overall safety of the therapy.
\u2714 Rapid Massive Manufacturing:<\/strong> CytoArm\u2019s platform enables rapid production within just 10 days, significantly faster than traditional methods. This quick turnaround ensures that patients receive timely treatment, which is critical in combating aggressive cancers.<\/div>\n<\/div>\n<\/div>\n <\/div><\/section>","protected":false},"excerpt":{"rendered":"","protected":false},"author":3,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_gspb_post_css":"#gspb_row-id-gsbp-c73ff72{justify-content:space-between;margin-top:0;display:flex;flex-wrap:wrap;margin-bottom:0;padding-top:90px;padding-bottom:90px}#gspb_row-id-gsbp-c73ff72>.gspb_row__content{display:flex;justify-content:space-between;margin:0 auto;width:100%;flex-wrap:wrap}div[id^=gspb_col-id]{box-sizing:border-box;position:relative;padding:15px min(3vw,20px)}body.gspb-bodyfront #gspb_row-id-gsbp-c73ff72>.gspb_row__content{width:var(--theme-container-width, 1290px);max-width:var(--theme-normal-container-max-width, 1290px)}@media (max-width:575.98px){#gspb_row-id-gsbp-c73ff72{padding-top:24px;padding-bottom:32px}}#gspb_row-id-gsbp-c73ff72{background-color:var(--wp--preset--color--palette-color-7, var(--theme-palette-color-7, #F7F7F7))}#gspb_col-id-gsbp-39002af.gspb_row__col--12{width:100%}@media (max-width:575.98px){#gspb_col-id-gsbp-39002af.gspb_row__col--12{width:100%}#gspb_heading-id-gsbp-22c8c4f{font-size:28px}}#gspb_heading-id-gsbp-22c8c4f,#gspb_heading-id-gsbp-22c8c4f .gsap-g-line{text-align:center!important}@media (max-width:575.98px){#gspb_heading-id-gsbp-22c8c4f,#gspb_heading-id-gsbp-22c8c4f .gsap-g-line{text-align:center!important}}#gspb_heading-id-gsbp-22c8c4f{color:var(--wp--preset--color--palette-color-1, var(--theme-palette-color-1, #00457B));margin-top:0;margin-bottom:28px}@media (max-width:575.98px){#gspb_heading-id-gsbp-22c8c4f{margin-bottom:24px}}.gspb_container-id-gsbp-a151bc8{flex-direction:column;box-sizing:border-box}#gspb_container-id-gsbp-8504f09.gspb_container>p:last-of-type,#gspb_container-id-gsbp-a151bc8.gspb_container>p:last-of-type,#gspb_container-id-gsbp-be2dcc6.gspb_container>p:last-of-type,#gspb_container-id-gsbp-cc4329f.gspb_container>p:last-of-type,#gspb_container-id-gsbp-cc72412.gspb_container>p:last-of-type{margin-bottom:0}#gspb_container-id-gsbp-a151bc8.gspb_container{display:flex;flex-direction:column;align-items:center;margin-bottom:0;padding-right:180px;padding-left:180px}@media (max-width:575.98px){#gspb_container-id-gsbp-a151bc8.gspb_container{padding-right:8px;padding-left:8px}}.gspb_text-id-gsbp-70f29e2{color:var(--wp--preset--color--palette-color-3, var(--theme-palette-color-3, #202020));margin-top:0!important;margin-bottom:0!important}#gspb_row-id-gsbp-654909c{justify-content:space-between;margin-bottom:0;display:flex;flex-wrap:wrap;margin-top:0;padding-top:90px;padding-bottom:90px}#gspb_row-id-gsbp-654909c>.gspb_row__content{display:flex;justify-content:space-between;margin:0 auto;width:100%;flex-wrap:wrap}.gspb_row{position:relative}body.gspb-bodyfront #gspb_row-id-gsbp-654909c>.gspb_row__content{width:var(--theme-container-width, 1290px);max-width:var(--theme-normal-container-max-width, 1290px)}@media (max-width:575.98px){#gspb_row-id-gsbp-654909c{padding-top:24px;padding-bottom:32px}}#gspb_row-id-gsbp-654909c{background-color:var(--wp--preset--color--palette-color-8, var(--theme-palette-color-8, #ffffff))}#gspb_col-id-gsbp-bed39a6.gspb_row__col--12{width:100%}@media (max-width:575.98px){#gspb_col-id-gsbp-bed39a6.gspb_row__col--12{width:100%}}.gspb_row #gspb_col-id-gsbp-bed39a6.gspb_row__col--12{margin-bottom:80px}@media (max-width:575.98px){.gspb_row #gspb_col-id-gsbp-bed39a6.gspb_row__col--12{margin-bottom:32px}}#gspb_container-id-gsbp-8504f09.gspb_container{display:flex;flex-direction:column;align-items:center;margin-bottom:4px;padding-right:180px;padding-left:180px}@media (max-width:575.98px){#gspb_container-id-gsbp-8504f09.gspb_container{margin-bottom:24px;padding-right:8px;padding-left:8px}#gspb_heading-id-gsbp-93ba0f2{font-size:28px}}#gspb_heading-id-gsbp-93ba0f2,#gspb_heading-id-gsbp-93ba0f2 .gsap-g-line{text-align:center!important}@media (max-width:575.98px){#gspb_heading-id-gsbp-93ba0f2,#gspb_heading-id-gsbp-93ba0f2 .gsap-g-line{text-align:center!important}}#gspb_heading-id-gsbp-93ba0f2{color:var(--wp--preset--color--palette-color-1, var(--theme-palette-color-1, #00457B));margin-top:0;margin-bottom:8px}@media (max-width:575.98px){#gspb_heading-id-gsbp-93ba0f2{margin-bottom:16px}}.gspb_container-id-gsbp-8504f09,.gspb_container-id-gsbp-cc4329f{flex-direction:column;box-sizing:border-box}#gspb_container-id-gsbp-cc4329f.gspb_container{display:flex;flex-direction:column;align-items:center;margin-bottom:0;padding-right:180px;padding-left:180px}@media (max-width:575.98px){#gspb_container-id-gsbp-cc4329f.gspb_container{padding-right:8px;padding-left:8px}}.gspb_text-id-gsbp-7fe1838{color:var(--wp--preset--color--palette-color-3, var(--theme-palette-color-3, #202020));margin-bottom:0!important}#gspb_col-id-gsbp-8d1206d.gspb_row__col--12{width:100%}@media (max-width:575.98px){#gspb_col-id-gsbp-8d1206d.gspb_row__col--12{width:100%}}#gspb_container-id-gsbp-cc72412.gspb_container{display:flex;flex-direction:column;align-items:center;margin-bottom:32px;padding-right:180px;padding-left:180px}@media (max-width:575.98px){#gspb_container-id-gsbp-cc72412.gspb_container{margin-bottom:24px;padding-right:8px;padding-left:8px}#gspb_heading-id-gsbp-be0188e{font-size:28px}}#gspb_heading-id-gsbp-be0188e,#gspb_heading-id-gsbp-be0188e .gsap-g-line{text-align:center!important}@media (max-width:575.98px){#gspb_heading-id-gsbp-be0188e,#gspb_heading-id-gsbp-be0188e .gsap-g-line{text-align:center!important}}#gspb_heading-id-gsbp-be0188e{color:var(--wp--preset--color--palette-color-1, var(--theme-palette-color-1, #00457B));margin-top:0;margin-bottom:8px}@media (max-width:575.98px){#gspb_heading-id-gsbp-be0188e{margin-bottom:16px}#gspb_heading-id-gsbp-f378de2{font-size:20px}}#gspb_heading-id-gsbp-f378de2,#gspb_heading-id-gsbp-f378de2 .gsap-g-line{text-align:center!important}@media (max-width:575.98px){#gspb_heading-id-gsbp-f378de2,#gspb_heading-id-gsbp-f378de2 .gsap-g-line{text-align:center!important}}#gspb_heading-id-gsbp-f378de2{color:var(--wp--preset--color--palette-color-1, var(--theme-palette-color-1, #00457B));margin-top:0;margin-bottom:0}@media (max-width:575.98px){#gspb_heading-id-gsbp-f378de2{margin-bottom:0}}.gspb_container-id-gsbp-be2dcc6,.gspb_container-id-gsbp-cc72412{flex-direction:column;box-sizing:border-box}.gspb_container{position:relative}#gspb_container-id-gsbp-be2dcc6.gspb_container{display:flex;flex-direction:column;align-items:center;margin-bottom:0;padding-right:180px;padding-left:180px}@media (max-width:575.98px){#gspb_container-id-gsbp-be2dcc6.gspb_container{padding-right:8px;padding-left:8px}}.gspb_text-id-gsbp-e6ab423{color:var(--wp--preset--color--palette-color-3, var(--theme-palette-color-3, #202020));margin-bottom:40px!important}","footnotes":""},"class_list":["post-956","page","type-page","status-publish","hentry"],"blocksy_meta":{"has_hero_section":"disabled","vertical_spacing_source":"custom","content_area_spacing":"none","styles_descriptor":{"styles":{"desktop":"","tablet":"","mobile":""},"google_fonts":[],"version":6},"page_structure_type":"default"},"_links":{"self":[{"href":"https:\/\/cytoarm.com\/zh\/wp-json\/wp\/v2\/pages\/956","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cytoarm.com\/zh\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/cytoarm.com\/zh\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/cytoarm.com\/zh\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/cytoarm.com\/zh\/wp-json\/wp\/v2\/comments?post=956"}],"version-history":[{"count":0,"href":"https:\/\/cytoarm.com\/zh\/wp-json\/wp\/v2\/pages\/956\/revisions"}],"wp:attachment":[{"href":"https:\/\/cytoarm.com\/zh\/wp-json\/wp\/v2\/media?parent=956"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}